This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
8
Check minimum number of events None
8
Include endpoints None
8
Remove individuals based on genotype QC
7
E4_AMYL_NEUROHER
Control definitions
Control exclude
E4_METABOLIA
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E85
Name in latin
Amyloidosis (heredo)familialis neuropathica
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Neuropathic heredofamilial amyloidosis
based on the number of shared cases.
Broader endpoints:
- Amyloidosis
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Anti-inflammatory and antirheumatic products, non-steroids
- Paracetamol of NSAID medication
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 7 | - | - |
| Unadjusted prevalence (%) | 0.00 | - | - |
| Mean age at first event (years) | 57.36 | - | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_AMYL_NEUROHER – Neuropathic heredofamilial amyloidosis
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Neuropathic heredofamilial amyloidosis
↥Endpoint not on priority list, no data to show.